Buy Flibanserin in Ukraine

What is FLIBANSERIN?

FLIBANSERIN is a centrally acting medication designed to treat acquired generalized hypoactive sexual desire disorder in specific categories of women. This condition manifests as a persistent decrease in sexual desire that causes marked psychological distress or interpersonal difficulties. The drug is not a hormonal agent, an aphrodisiac, or an instant stimulant. Its therapeutic effect develops gradually due to its influence on the neurotransmitter systems of the brain.

FLIBANSERIN belongs to psychotropic agents with serotonin-modulating activity. It is usually produced in the form of tablets for oral administration, most often with a dosage of 100 mg of the active substance. The medication is taken regularly, rather than immediately before sexual activity. The release form, coating composition, and number of tablets in the package may vary depending on the brand and supplier.

The manufacturer of a specific product must be verified on the packaging, in the quality certificate, or in the official instructions, as it is not specified in the source data. FLIBANSERIN is a prescription drug in countries where it has state registration, so self-administration is unacceptable. Before starting treatment, a doctor's consultation is required to confirm the diagnosis and rule out other causes of low libido. Such causes include illnesses, side effects of medications, relationship conflicts, and psychoemotional disorders.

What is FLIBANSERIN prescribed for?

The primary indication is acquired generalized hypoactive sexual desire disorder in women for whom the drug is approved by the relevant official instructions. "Acquired" means that the level of sexual desire was previously satisfactory, and "generalized" means that the problem is not limited to a specific partner, situation, or type of stimulation. The decrease in desire must cause clinically significant distress, meaning noticeable emotional tension or dissatisfaction. The final diagnosis is established by a doctor after a delicate interview and assessment of the general condition.

FLIBANSERIN is not intended to "improve sexual performance" in the absence of a medical disorder. It also does not treat pain during intercourse, vaginal dryness, orgasmic disorder, or erectile dysfunction in men. If symptoms are related to depression, anxiety disorder, endocrine disease, the effects of antidepressants, or other factors, the underlying cause is corrected first. The expected result is a moderate increase in sexual desire and a reduction in related distress.

Before prescribing, the duration of symptoms, concomitant diseases, liver function, alcohol consumption, and all medications used are evaluated. It is important to rule out relationship problems as the sole cause of complaints, as well as abuse, severe exhaustion, and uncontrolled psychiatric conditions. The efficacy of FLIBANSERIN is individual, so a positive response does not occur in every patient. If there is no clinically significant improvement after the recommended evaluation period, the doctor usually discontinues therapy.

Composition and Active Components of FLIBANSERIN

The active component is flibanserin, the amount of which is indicated on the packaging and in the instructions of the specific drug. The substance acts as an agonist of serotonin 5-HT1A receptors and an antagonist of 5-HT2A receptors, meaning it alters signal transmission between nerve cells. This action is believed to reduce serotonin activity and modulate dopamine and norepinephrine levels in brain regions associated with sexual motivation. The mechanism does not imply immediate arousal but requires systematic intake.

Excipients ensure the stability of the tablet, the required shape, disintegration, and absorption of the active substance. The composition of different products may include fillers, binders, stabilizers, film coating components, and colorants. The exact list should be checked in the official instructions, especially in case of allergies, lactose intolerance, or other excipients. Auxiliary ingredients do not provide the main therapeutic effect but may be important for the safety of a specific patient.

Dosage of FLIBANSERIN

A typical regimen for adult women involves 100 mg once daily at bedtime, if this specific dosage is approved in the instructions of the registered drug. Evening administration reduces the risk of injury due to somnolence, dizziness, arterial hypotension, or fainting during waking hours. Exceeding the daily dose or taking tablets more frequently is prohibited, as this does not accelerate the effect and increases the risk of adverse reactions. The individual regimen is determined by a doctor, taking into account the state of health and concomitant treatment.

The therapeutic response is usually evaluated within eight weeks of regular use. If no noticeable improvement in desire or reduction in distress is observed by this time, continuation of treatment is often considered inappropriate. Unauthorized increase of the dose, splitting the tablet, or restarting the drug after a break should not be done. Regimen adjustment may be required after the onset of adverse reactions, changes in other medications, or violations of alcohol consumption guidelines.

FLIBANSERIN is not used under the standard regimen in patients with hepatic impairment and in the presence of dangerous drug interactions. There is no special dosage for a "quick effect" before sexual intercourse. The duration of the course is determined by efficacy, tolerability, and current official instructions. Any dose change must occur only after consultation with a doctor.

How to take FLIBANSERIN correctly?

The tablet is swallowed whole with water, daily at approximately the same time before bedtime. Administration relative to food should be coordinated with the instructions of the specific product, as food can affect the rate and extent of absorption. The drug should not be taken during the day or immediately before activities requiring rapid reaction. Regularity is more important than linking the tablet to planned sexual activity.

If the evening dose is missed, it is not taken in the morning and is not doubled the next day. Treatment is continued the following evening at the usual time. After an accidental overdose, medical assistance must be sought, especially if severe weakness, fainting, or impaired consciousness occurs. Until recommendations are received, one should not drive a car or remain unattended.

Before starting administration, the doctor must be informed about all prescription and over-the-counter medicines, herbal supplements, and alcohol consumption. FLIBANSERIN must not be combined independently with sedatives or agents that affect its metabolism. The individual response of the body may vary even when the standard regimen is followed. If unusual symptoms appear, a professional evaluation is required, rather than self-adjustment of treatment.

Side Effects of FLIBANSERIN

The most common adverse reactions include dizziness, somnolence, nausea, fatigue, insomnia, and dry mouth. Headache, decreased concentration, feeling of weakness, and gastrointestinal discomfort are possible. Such manifestations occur more frequently at the beginning of treatment and may be exacerbated by alcohol or other central nervous system depressants. Even moderate drowsiness requires caution during daily activities.

Uncommon but clinically important reactions include a significant decrease in blood pressure, presyncope, and syncope. The risk increases with hepatic impairment, interactions with certain medications, incorrect timing of administration, or alcohol consumption. Rarely, a hypersensitivity reaction with rash, facial swelling, difficulty breathing or swallowing is possible. Such symptoms require emergency medical care.

A doctor should be consulted in case of recurrent dizziness, falls, palpitations, persistent vomiting, or pronounced daytime sleepiness. Fainting, difficulty breathing, and impaired consciousness are grounds for an urgent emergency call. The list of reactions may vary depending on the specific drug and the patient's condition. Safety is evaluated individually, weighing the expected benefit against the possible risk.

Contraindications of FLIBANSERIN

An absolute contraindication is hypersensitivity to the active substance or excipients. The drug is not used in patients with hepatic impairment due to the risk of increased flibanserin concentration and the development of severe hypotension. Concomitant use of moderate or strong inhibitors of the CYP3A4 enzyme, which is involved in the breakdown of the drug, can be dangerous. The exact list of incompatible agents is determined by the official instructions and the patient's prescriptions.

FLIBANSERIN is not intended for children and adolescents and is not used to treat sexual disorders in men. During pregnancy, the drug is used only when the doctor considers the potential benefit to outweigh the possible risk, as there are insufficient safety data. During lactation, discontinuation of the drug or cessation of breastfeeding is usually considered after medical evaluation. Self-administration in these groups is unacceptable.

For elderly patients, data on efficacy and safety are limited, and the risk of dizziness, falls, and interactions may be higher. Caution is required in case of low blood pressure, predisposition to fainting, and concomitant use of sleeping pills or sedatives. Before treatment, it is important to evaluate the mental state, concomitant diseases, and all risk factors. Consultation with a doctor before taking FLIBANSERIN is mandatory.

Interaction of FLIBANSERIN with other drugs and alcohol

FLIBANSERIN is metabolized primarily by the CYP3A4 enzyme, so its concentration can be increased by certain antifungals, macrolide antibiotics, antivirals, and grapefruit juice. Other medicines, conversely, can accelerate breakdown and weaken the effect, including certain anticonvulsants and St. John's wort preparations. Combination with sleeping pills, benzodiazepines, opioids, or sedative antihistamines increases drowsiness and impaired coordination. All combinations must be checked by a doctor or clinical pharmacist.

Alcohol increases the risk of severe hypotension, syncope, and central nervous system depression, so it is necessary to strictly follow the rules of the current instructions regarding the interval or complete avoidance of alcohol. If alcohol was consumed shortly before the planned dose, professional advice should be obtained, and one should not improvise with the regimen. After taking the medication, one must not drive at least until the next day or longer if drowsiness or dizziness persists. Returning to driving is permissible only after attention and reaction speed are fully restored.

Where to buy FLIBANSERIN in Ukraine

You can buy FLIBANSERIN in Ukraine only subject to the legal registration of the specific medicinal product and its availability in licensed pharmacies. Before ordering, it is worth checking the registration status, manufacturer, dosage, batch, expiration date, integrity of the packaging, and the presence of instructions in Ukrainian. Online orders should be placed through a legal pharmacy chain that complies with prescription dispensing and proper delivery conditions. Offers without confirmed origin pose a risk of purchasing a counterfeit or improperly stored product.

The drug must be stored in its original packaging, in a dry place inaccessible to children, at the temperature specified by the manufacturer. Delivery must not violate the recommended temperature regime or the integrity of the tablets. Do not use the product after the expiration date or if the packaging is damaged. This description is for informational purposes and does not replace the official instructions, diagnosis, and consultation with a doctor before starting treatment.